[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TWI381829B - Polymerizable water-soluble or alcohol-soluble uv-light absorbent - Google Patents

Polymerizable water-soluble or alcohol-soluble uv-light absorbent Download PDF

Info

Publication number
TWI381829B
TWI381829B TW97104292A TW97104292A TWI381829B TW I381829 B TWI381829 B TW I381829B TW 97104292 A TW97104292 A TW 97104292A TW 97104292 A TW97104292 A TW 97104292A TW I381829 B TWI381829 B TW I381829B
Authority
TW
Taiwan
Prior art keywords
compound
hydrogen
formula
soluble
ultraviolet light
Prior art date
Application number
TW97104292A
Other languages
Chinese (zh)
Other versions
TW200934458A (en
Inventor
Chiu Ming Hung
Wwi Ju Chen
Cheng Han Chung
Chih Kang Chang
Hsiang Lin Jiang
You Chin Mou
Yen Cheng Li
Chi Hsiang Yao
Original Assignee
Everlight Chem Ind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Everlight Chem Ind Corp filed Critical Everlight Chem Ind Corp
Priority to TW97104292A priority Critical patent/TWI381829B/en
Publication of TW200934458A publication Critical patent/TW200934458A/en
Application granted granted Critical
Publication of TWI381829B publication Critical patent/TWI381829B/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

可聚合型水溶性或醇溶性紫外光吸收劑Polymerizable water-soluble or alcohol-soluble ultraviolet light absorber

本發明係關於一種新穎的可聚合型水溶性或醇溶性紫外光吸收劑,本發明並揭露該新穎化學品其製造方法及其在光學醫藥材料上的應用。The present invention relates to a novel polymerizable water-soluble or alcohol-soluble ultraviolet light absorber, and the present invention also discloses a method for producing the novel chemical and its use in optical medical materials.

日光中之紫外線大部分係以波長介於290 nm~400 nm之輻射能照射至地球表面。短波長低於175 nm之紫外光線約在100公里緯度層會被氧吸收,而輻射介於175 nm至290 nm之紫外線約在海平面上15公里處會被臭氧層吸收。眾所週知,暴露於紫外線輻射下,不但會傷害皮膚,亦會造成角膜損傷及視覺上之症狀,也是造成形成白內障的主要原因之一。因此如何提供足夠視覺保護以對抗紫外線輻射,降低白內障發病率機會,及保護特殊易受紫外線傷害的人們,例如經眼睛手術治療之病人或是對光敏感之病人,即為一亟受注重之問題。Most of the ultraviolet light in sunlight is irradiated to the surface of the earth with radiant energy having a wavelength between 290 nm and 400 nm. Ultraviolet light with a short wavelength below 175 nm is absorbed by oxygen at about 100 km latitude, while ultraviolet rays with radiation between 175 nm and 290 nm are absorbed by the ozone layer at about 15 km above sea level. It is well known that exposure to ultraviolet radiation not only damages the skin, but also causes corneal damage and visual symptoms, and is one of the main causes of cataract formation. Therefore, how to provide adequate visual protection against UV radiation, reduce the chance of cataract incidence, and protect people who are particularly vulnerable to UV rays, such as patients undergoing eye surgery or patients sensitive to light, is a matter of concern. .

一般而言,添加紫外線吸收劑於隱形眼鏡或是一般眼鏡組成中,可藉由吸收290 nm至400 nm區域間之紫外線而使有害的紫外線輻射效應減小,不僅可保護視覺系統並且可降低白內障發病率機會。至今為止,已有許多種不同類型之紫外線吸收劑被開發且有效應用於隱形眼鏡或一般眼鏡組成中,但若要防止在不同使用環境下紫外線吸收劑可能由鏡片流失之缺點,通常較佳之方法是使鏡片材料與可聚合型紫外線吸收劑反應接枝或共聚合。例如,美國專利US4,304,895所揭露使用於隱型眼鏡之可反應型紫外光吸收劑,如下式: In general, the addition of UV absorbers to contact lenses or general glasses can reduce the harmful effects of UV radiation by absorbing UV light between 290 nm and 400 nm, which not only protects the vision system but also reduces cataracts. Incidence rate opportunities. So far, many different types of UV absorbers have been developed and effectively used in contact lens or general eyeglasses. However, it is generally preferred to prevent the UV absorber from being lost by the lens in different environments. The grafting or copolymerization of the lens material with the polymerizable ultraviolet absorber is carried out. For example, U.S. Patent No. 4,304,895 discloses a reactive ultraviolet light absorber for use in contact lenses, as follows:

雖然上述具反應基之二苯甲酮類紫外線吸收劑可參與聚合,但此類型之紫外線吸收劑穩定性較差。當其應用於鏡片時,該類型吸收劑抗紫外光性能,常會因鏡片使用期及儲存期時,慢慢的減弱。同時,上述之紫外線吸收劑是疏水的,在親水性佳的壓克力共聚單體和共聚物中則不溶。即便這些化合物稍微能溶解於親水共聚單體和共聚物,然而當共聚物發生水合時,它們傾向於從微相分離狀發生凝聚。此凝聚現象使材料變成霧狀,破壞材料的透明性。Although the above-mentioned reactive benzophenone-based ultraviolet absorber can participate in polymerization, this type of ultraviolet absorber is inferior in stability. When applied to a lens, the anti-ultraviolet property of the type of absorbent is often slowly attenuated due to the period of use and storage of the lens. At the same time, the above ultraviolet absorber is hydrophobic and insoluble in the hydrophilic acrylic comonomer and copolymer. Even though these compounds are slightly soluble in hydrophilic comonomers and copolymers, when the copolymers hydrate, they tend to agglomerate from the microphase separation. This agglomeration causes the material to become foggy, destroying the transparency of the material.

另外,美國專利US4,528,311所揭露之可反應型紫外光吸收劑,如下式: In addition, the reactive ultraviolet light absorber disclosed in U.S. Patent No. 4,528,311 is as follows:

上述苯並三唑類型之紫外線吸收劑是可聚合的,且具較佳穩定性,但該化合物仍傾向疏水性,疏水特性將導致微相分離及霧狀現象產生。The above-mentioned benzotriazole type ultraviolet absorber is polymerizable and has good stability, but the compound still tends to be hydrophobic, and the hydrophobic property causes microphase separation and haze formation.

而,美國專利US6,036,891所揭露的紫外光吸收劑,使用新化合物2-(2’-羥基-5’-羥基乙氧基乙基苯基)-2H-苯並三唑(2-(2’-hydroxy-5’-hydroxyethoxyethylphenyl)-2H-benzotriazole)與甲基丙烯醯氯(methacryloyl chloride)進行反應,產生單酯(mono-ester)類化合物,如下式: The ultraviolet light absorber disclosed in U.S. Patent No. 6,036,891, the new compound 2-(2'-hydroxy-5'-hydroxyethoxyethylphenyl)-2H-benzotriazole (2-(2) '-hydroxy-5'-hydroxyethoxyethylphenyl)-2H-benzotriazole is reacted with methacryloyl chloride to produce a mono-ester compound as follows:

不過,上述專利說明書中並未提及如何獲得新化合物2-(2’-羥基-5’-羥基乙氧基乙基苯基)-2H-苯並三唑,亦未提供關鍵原料之合成方法,應是該發明專利一大缺憾,同時所得反應型紫外光吸收劑,雖較以往所發展之吸收劑提升了親水性能,但其水溶性仍然偏低。日本專利JP3655061中所提供之紫外光吸收劑,如下式: However, the above patent specification does not mention how to obtain the new compound 2-(2'-hydroxy-5'-hydroxyethoxyethylphenyl)-2H-benzotriazole, nor does it provide a synthetic method for the key raw materials. It should be a big flaw of the invention patent. At the same time, the obtained reactive ultraviolet light absorber has higher hydrophilicity than the absorbent developed by the prior art, but its water solubility is still low. The ultraviolet light absorber provided in Japanese Patent JP3655061 is as follows:

亦遇到水溶性仍然偏低的問題。There is also the problem that water solubility is still low.

親水性和水溶性或醇溶性是不同的性質,由於製成隱形眼鏡材料必需有親水性,鏡片才能跟著眼珠移動,而達到校正視力的功能,且親水性可以增加舒適度。由於隱形眼鏡或人工水晶體親水性的重要性,所以製造鏡片的原料,必須要有親水性。在合成後,少量沒有聚合的成分,必須洗除掉,以保證沒有毒性。一般以來,在製造的程序中,必須用大量的溶劑去洗除剩餘未反應之單體,不但費時費力,更會增加成本。若使用具水溶性或醇溶性佳的成分進行反應,不但材料聚合後,不會有霧狀的產生,並且在洗除剩餘未反應之單體時,沒有揮發性有機物(VOC)排放及環保問題,亦可減低生產成本。Hydrophilicity and water solubility or alcohol solubility are different properties. Since the contact lens material must be hydrophilic, the lens can follow the eyeball to achieve the function of correcting vision, and the hydrophilicity can increase the comfort. Due to the importance of the hydrophilicity of contact lenses or artificial crystals, the raw materials for the manufacture of lenses must be hydrophilic. After synthesis, a small amount of non-polymerized ingredients must be washed away to ensure no toxicity. In general, in the manufacturing process, a large amount of solvent must be used to wash away the remaining unreacted monomers, which is time consuming and laborious, and increases the cost. If a water-soluble or alcohol-soluble component is used for the reaction, not only will the material be produced after the polymerization, but there will be no volatile organic compounds (VOC) emissions and environmental problems when the remaining unreacted monomers are washed away. It can also reduce production costs.

我方發明之新穎性式(I)可聚合型的紫外光吸收劑屬於雙酯(di-ester)類化合物,同時具有極佳之水溶性或醇溶性,與親水性或水溶性佳的單體進行反應,將可穩定的產出良好透明性佳之共聚合產物。The novel formula (I) polymerizable ultraviolet light absorber of our invention belongs to the class of di-ester compounds, and has excellent water solubility or alcohol solubility, and monomer with good hydrophilicity or water solubility. By carrying out the reaction, it is possible to stably produce a copolymerized product which is excellent in transparency and good in transparency.

本發明提供一種新穎的可聚合型水溶性或醇溶性紫外光吸收劑,其係如下式(I)所示: 其中,R1 為氫或C1 -C5 烷基,R2 為氫、氯、溴、或碘,R3 為氫或甲基,且m為3~12。The present invention provides a novel polymerizable water-soluble or alcohol-soluble ultraviolet light absorber which is represented by the following formula (I): Wherein R 1 is hydrogen or C 1 -C 5 alkyl, R 2 is hydrogen, chlorine, bromine or iodine, R 3 is hydrogen or methyl, and m is from 3 to 12.

本發明亦提供一種共聚物,其係由式(I)所示化合物與親水性或水溶性單體,進行聚合反應而形成。如此所得之共聚物,具有光學性且為透明聚合物,可用於製造光學醫藥材料如隱形眼鏡或人工水晶體等等。The present invention also provides a copolymer which is formed by polymerizing a compound represented by the formula (I) with a hydrophilic or water-soluble monomer. The copolymer thus obtained, which is optical and transparent, can be used for the manufacture of optical medical materials such as contact lenses or artificial crystals and the like.

本發明所提供之新穎的可聚合型水溶性紫外光吸收劑,係如下式(I)所示: 其中,R1 為氫或C1 -C5 烷基,R2 為氫、氯、溴、或碘,R3 為氫或甲基,且m為3~12。The novel polymerizable water-soluble ultraviolet light absorber provided by the present invention is represented by the following formula (I): Wherein R 1 is hydrogen or C 1 -C 5 alkyl, R 2 is hydrogen, chlorine, bromine or iodine, R 3 is hydrogen or methyl, and m is from 3 to 12.

上述式(I)化合物之製備方法,說明如下。經由如下式(II)之化合物, 與式(III)之聚乙二醇(PEG;polyethylene glycol)進行反應, 獲得式(IV)化合物, 再將式(IV)化合物與式(V)之丙烯酸類化合物進行反應, 獲得式(I)之化合物。其中,R1 、R2 、m、R3 如上述定義,而x為3~12。The preparation method of the above compound of the formula (I) is explained below. Via a compound of formula (II) below, Reacting with polyethylene glycol (PEG) of formula (III), Obtaining a compound of formula (IV), Further reacting a compound of formula (IV) with an acrylic compound of formula (V), A compound of formula (I) is obtained. Wherein R 1 , R 2 , m, and R 3 are as defined above, and x is 3 to 12.

亦或,上述式(I)化合物之製備方法,也經由如下式(II)之化合物 與如下式(VI)之化合物進行反應, 而獲得式(I)之化合物。其中,R1 、R2 、R3 如上述定義,而n為3~12。Or, the method for preparing the compound of the above formula (I) is also via a compound of the following formula (II) Reacting with a compound of the following formula (VI), The compound of formula (I) is obtained. Wherein R 1 , R 2 , and R 3 are as defined above, and n is 3 to 12.

本發明上述式(I)水溶性化合物,同樣具有極佳之醇溶性(alcohol-soluble),而適合應用在製造親水性佳之隱形眼鏡或人工水晶體。The water-soluble compound of the above formula (I) of the present invention also has excellent alcohol-soluble, and is suitable for use in the manufacture of a contact lens or an artificial crystal having good hydrophilicity.

本發明中式(I)化合物較佳者,舉例如下: 化合物(I)-a:R1 =H,R2 =H,R3 =H,m=6-8;化合物(I)-b:R1 =H,R2 =H,R3 =CH3 ,m=9-11;化合物(I)-c:R1 =H,R2 =H,R3 =CH3 ,m=5-7;化合物(I)-d:R1 =C(CH3 )3 ,R2 =H,R3 =CH3 ,m=5-7;化合物(I)-e:R1 =C(CH3 )3 ,R2 =H,R3 =CH3 ,m=3-5。Preferred compounds of the formula (I) in the present invention are exemplified as follows: Compound (I)-a: R 1 = H, R 2 = H, R 3 = H, m = 6-8; Compound (I)-b: R 1 = H, R 2 = H, R 3 = CH 3 m=9-11; compound (I)-c: R 1 =H, R 2 =H, R 3 =CH 3 , m=5-7; compound (I)-d: R 1 =C (CH 3 3 , R 2 =H, R 3 =CH 3 , m=5-7; compound (I)-e: R 1 =C(CH 3 ) 3 , R 2 =H, R 3 =CH 3 ,m= 3-5.

本發明亦提供一種共聚物,其係由式(I)化合物與親水性或水溶性單體進行聚合反應而形成。如此所得之親水性佳且具光學性的透明聚合物,可用於隱形眼鏡或人工水晶體的製造,並可簡化以後未反應單體的洗除(extract)步驟。適當之親水性材料包含所謂的水凝膠(hydrogel)或矽水凝膠(silicone hydrogel)。The present invention also provides a copolymer formed by polymerizing a compound of the formula (I) with a hydrophilic or water-soluble monomer. The hydrophilic polymer having good hydrophilicity and optical properties thus obtained can be used for the manufacture of contact lenses or artificial crystals, and can simplify the extraction step of unreacted monomers in the future. Suitable hydrophilic materials comprise so-called hydrogels or silicone hydrogels.

本發明式(I)化合物與親水性或水溶性單體所進行之聚合反應,可藉由任何已知方法進行。其進行之製程與條件係為一般熟諳此藝者所習知,一般依需求可能選擇加入其它添加劑至欲進行之反應中,適當之添加劑包括但不限於交聯劑、介面活性劑、稀釋劑、安定劑、光起始劑、染料等等。The polymerization of the compound of the formula (I) of the present invention with a hydrophilic or water-soluble monomer can be carried out by any known method. The processes and conditions are generally known to those skilled in the art. Generally, other additives may be added to the reaction to be carried out according to requirements. Suitable additives include, but are not limited to, crosslinking agents, surfactants, diluents, Stabilizers, photoinitiators, dyes, etc.

為方便更進一步說明起見,將列舉以下實施例做更具體的說明。For the sake of further explanation, the following examples will be more specifically described.

本發明接著將參考以下各實施例做更詳盡之說明,唯非用以限制本發明之範圍,任何熟悉此項技藝之人士可輕易達成之修飾及改變,均涵蓋在本範圍之內。除非特別說明,實施例中所使用的百分比皆以重量為單位,溫度以攝氏溫度℃為單位。The invention is further described with reference to the following examples, which are not intended to limit the scope of the invention, and the modifications and variations that can be easily made by those skilled in the art are included in the scope. Unless otherwise stated, the percentages used in the examples are by weight and the temperature is in degrees Celsius.

實施例Example

實施例中所提到之化合物結構如下所示: 化合物(I)-a:R1 =H,R2 =H,R3 =H,m=6-8;化合物(I)-b:R1 =H,R2 =H,R3 =CH3 ,m=9-11;化合物(I)-c:R1 =H,R2 =H,R3 =CH3 ,m=5-7;化合物(I)-d:R1 =C(CH3 )3 ,R2 =H,R3 =CH3 ,m=5-7;化合物(I)-e:R1 =C(CH3 )3 ,R2 =H,R3 =CH3 ,m=3-5。The structure of the compounds mentioned in the examples is as follows: Compound (I)-a: R 1 = H, R 2 = H, R 3 = H, m = 6-8; Compound (I)-b: R 1 = H, R 2 = H, R 3 = CH 3 m=9-11; compound (I)-c: R 1 =H, R 2 =H, R 3 =CH 3 , m=5-7; compound (I)-d: R 1 =C (CH 3 3 , R 2 =H, R 3 =CH 3 , m=5-7; compound (I)-e: R 1 =C(CH 3 ) 3 , R 2 =H, R 3 =CH 3 ,m= 3-5.

式(II)-1:R1 =H,R2 =H;式(II)-2:R1 =C(CH3 )3 ,R2 =H;PEG375AA:,n=6-8,購於Aldrich公司;PEG360MA:,n=5-7,購於Aldrich公司;PEG526MA:,n=9-11,購於Aldrich公司;PEG200:,x=3-5,購於Fluka公司。 Formula (II)-1: R 1 =H, R 2 =H; Formula (II)-2: R 1 =C(CH 3 ) 3 , R 2 =H; PEG375AA: , n=6-8, purchased from Aldrich; PEG360MA: , n=5-7, purchased from Aldrich; PEG526MA: , n=9-11, purchased from Aldrich; PEG200: , x = 3-5, purchased from Fluka.

實施例一Embodiment 1

化合物(I)-a製備 將20克式(II)-1化合物、26.8克PEG375AA、2.7克對甲苯磺酸(PTSA;p-Toluenesulfonic acid)及100克甲苯置入1公升四頸反應瓶中;反應瓶中分別裝有溫度計及蒸餾除水裝置。將反應瓶於攪拌加熱器上攪拌加熱至112℃後,於蒸餾除水裝置中收集水份約1毫升後以TLC觀察反應是否完全,降溫至90℃後,保持溫度下緩慢加入100毫升1N碳酸氫鈉(NaHCO3 )水溶液攪拌15分鐘,將混合溶液倒入萃取瓶中靜置分層,將下層水溶液倒入廢液桶中,再加入100毫升1N NaHCO3 水溶液倒入萃取瓶混合後靜置分層,將下層水溶液丟棄,收集有機層濃縮得45克粗產物(I)-a。 Preparation of Compound (I)-a 20 g of the compound of the formula (II)-1, 26.8 g of PEG375AA, 2.7 g of p-Toluenesulfonic acid and 100 g of toluene were placed in a 1 liter four-neck reaction flask; The reaction flask is equipped with a thermometer and a distillation water removal device, respectively. The reaction flask was stirred and heated to 112 ° C on a stirring heater. After collecting about 1 ml of water in a distillation water removal device, the reaction was observed by TLC. After cooling to 90 ° C, 100 ml of 1 N carbonic acid was slowly added while maintaining the temperature. The sodium hydrogen hydride (NaHCO 3 ) aqueous solution was stirred for 15 minutes. The mixed solution was poured into an extraction flask and allowed to stand for separation. The lower aqueous solution was poured into a waste liquid tank, and then 100 ml of a 1 N NaHCO 3 aqueous solution was added and poured into an extraction flask, and then allowed to stand. The layers were separated, the lower aqueous solution was discarded, and the organic layer was concentrated to give 45 g of crude product (I)-a.

化合物(I)-a純化 將約300克(樣品的15倍量)的管柱充填物(廠牌:Waters;規格:preparative C18 125)與450毫升的甲醇均勻攪拌混合後,緩緩倒入管柱(廠牌:Pyrex;規格:25G3)中進行充填,待管柱中的充填物緊密壓實後以等量的去離子水將甲醇置換掉,再繼續以2公升沖堤液(甲醇:水=1:1)進行置換後,秤取粗產物(I)-a約20克緩緩倒入管柱中,先以約2公升沖堤液(甲醇:水=1:1)以每瓶200毫升的量進行沖提收集後,改用甲醇:水=7:3的沖堤液繼續充提收集並取樣以HPLC進行分析,約收集了4公升後開始有純度較高的目標產物出現,並以逆向TLC片(Merck RP-18 F254 S)進行沖堤終點判斷,待HPLC檢測結果完成後進行濃縮符合產品規格的樣品,即得到一呈現褐色油狀的目標產品。 Purification of Compound (I)-a Approximately 300 g (15 times the amount of the sample) of the column packing (label: Waters; specification: preparative C18 125 After uniformly mixing with 450 ml of methanol, slowly pour into the column (label: Pyrex; size: 25G3) for filling. After the packed material in the column is compacted, the same amount of deionized water will be used. After replacing the methanol, continue to replace it with 2 liters of dyke (methanol: water = 1:1), and then weigh about 20 grams of crude product (I)-a and slowly pour it into the column, first about 2 liters. Drainage liquid (methanol: water = 1:1) was extracted and collected in an amount of 200 ml per bottle, and then changed to methanol (water: 7:3), and the levee liquid was continuously charged and collected and sampled for analysis by HPLC. After collecting 4 liters, the target product with higher purity began to appear, and the reverse TLC sheet (Merck RP-18 F 254 S) was used to judge the end point of the bank. After the HPLC test result was completed, the sample conforming to the product specification was concentrated, that is, A target product in the form of a brown oil was obtained.

化合物(I)-a圖譜 1 H NMR(CDCl3 ):δ:11.18(s,1H),8.26(s,1H),7.90(q,2H),7.50(q,2H),7.20(d,1H),7.12(d,1H),6.41(m,1H),6.15(m,1H),5.82(m,1H),4.25(m,4H),3.63(m,24H),2.99(t,2H),2.68(t,2H)。 Compound (I)-a spectrum 1 H NMR (CDCl 3 ): δ: 11.18 (s, 1H), 8.26 (s, 1H), 7.90 (q, 2H), 7.50 (q, 2H), 7.20 (d, 1H) ), 7.12 (d, 1H), 6.41 (m, 1H), 6.15 (m, 1H), 5.82 (m, 1H), 4.25 (m, 4H), 3.63 (m, 24H), 2.99 (t, 2H) , 2.68 (t, 2H).

實施例二~四Embodiment 2~4

重複實施例一之合成及純化步驟,進行化合物(I)-b、化合物(I)-c及化合物(I)-d之製備,使用如表一之原料進行相關反應。The synthesis and purification steps of Example 1 were repeated, and the preparation of Compound (I)-b, Compound (I)-c and Compound (I)-d was carried out, and the relevant reaction was carried out using the starting materials of Table 1.

所得成品化合物(I)-b、化合物(I)-c、及化合物(I)-d相關1 H NMR圖譜如下。The 1 H NMR spectrum of the obtained finished compound (I)-b, compound (I)-c, and compound (I)-d was as follows.

化合物(I)-b圖譜 1 H NMR(CDCl3 ):δ:11.19(s,1H),8.26(s,1H),7.93(q,2H),7.52(q,2H),7.21(d,1H),7.12(d,1H),6.12(s,1H),5.56(s,1H),4.26(m,4H),3.63(m,36H),3.00(t,2H),2.69(t,2H),1.94(s,3H)。 Compound (I)-b spectrum 1 H NMR (CDCl 3 ): δ: 11.19 (s, 1H), 8.26 (s, 1H), 7.93 (q, 2H), 7.52 (q, 2H), 7.21 (d, 1H) ), 7.12 (d, 1H), 6.12 (s, 1H), 5.56 (s, 1H), 4.26 (m, 4H), 3.63 (m, 36H), 3.00 (t, 2H), 2.69 (t, 2H) , 1.94 (s, 3H).

化合物(I)-c圖譜 1 H NMR(CDCl3 ):δ:11.17(s,1H),8.24(s,1H),7.91(q,2H),7.47(q,2H),7.20(d,1H),7.11(d,1H),6.12(s,1H),5.56(s,1H),4.26(m,4H),3.63(m,20H),3.00(t,2H),2.69(t,2H),1.89(s,3H)。 Compound (I)-c spectrum 1 H NMR (CDCl 3 ): δ: 11.17 (s, 1H), 8.24 (s, 1H), 7.91 (q, 2H), 7.47 (q, 2H), 7.20 (d, 1H) ), 7.11 (d, 1H), 6.12 (s, 1H), 5.56 (s, 1H), 4.26 (m, 4H), 3.63 (m, 20H), 3.00 (t, 2H), 2.69 (t, 2H) , 1.89 (s, 3H).

化合物(I)-d圖譜 1 H NMR(CDCl3 ):δ:11.81(s,1H),8.14(s,1H),7.92(q,2H),7.47(q,2H),7.20(s,1H),6.12(s,1H),5.57(s,1H),4.28(m,4H),3.64(m,20H),3.00(t,2H),2.73(t,2H),1.94(s,3H),1.50(s,9H)。 Compound (I)-d spectrum 1 H NMR (CDCl 3 ): δ: 11.81 (s, 1H), 8.14 (s, 1H), 7.92 (q, 2H), 7.47 (q, 2H), 7.20 (s, 1H) ), 6.12 (s, 1H), 5.57 (s, 1H), 4.28 (m, 4H), 3.64 (m, 20H), 3.00 (t, 2H), 2.73 (t, 2H), 1.94 (s, 3H) , 1.50 (s, 9H).

實施例五Embodiment 5

化合物(I)-e之製備 將100克式(II)-2化合物、590克PEG200、5.6克對甲苯磺酸(PTSA)及500毫升甲苯置入1公升四頸反應瓶中;反應瓶中分別裝有溫度計及蒸餾除水裝置。將反應瓶於攪拌加熱器上攪拌加熱至112℃後,於蒸餾除水裝置中收集水份約5毫升後以TLC觀察反應是否完全,降溫至90℃後,保持溫度下緩慢加入468毫升水溶液攪拌15分鐘,將混合溶液倒入萃取瓶中靜置分層,將下層水溶液倒入廢液桶中,再加入400毫升水溶液倒入萃取瓶混合後靜置分層,將下層水溶液丟棄,收集有機層濃縮得162克產物。 Preparation of Compound (I)-e 100 g of the compound of the formula (II)-2, 590 g of PEG 200, 5.6 g of p-toluenesulfonic acid (PTSA) and 500 ml of toluene were placed in a 1 liter four-neck reaction flask; It is equipped with a thermometer and a distilled water removal device. The reaction flask was stirred and heated to 112 ° C on a stirring heater. After collecting about 5 ml of water in a distillation water removal device, the reaction was observed by TLC. After cooling to 90 ° C, slowly add 468 ml of the aqueous solution while maintaining the temperature. After 15 minutes, the mixed solution was poured into an extraction flask and allowed to stand for separation. The lower aqueous solution was poured into a waste liquid tank, and then 400 ml of an aqueous solution was added and poured into an extraction flask, and the mixture was allowed to stand for separation, and the lower aqueous solution was discarded, and the organic layer was collected. Concentrate to give 162 g of product.

將28.8克上述產物、8.8克甲基丙烯酸(Methacrylic acid.)、0.98克對甲苯磺酸(PTSA)及200 ml甲苯置入1公升四頸反應瓶中;反應瓶中分別裝有溫度計及蒸餾除水裝置。將反應瓶於攪拌加熱器上攪拌加熱至112℃後,於蒸餾除水裝置中收集水份約0.8毫升後以TLC觀察反應是否完全,待反應完全後,降溫至90℃後,保持溫度下緩慢加入200毫升1N碳酸氫鈉(NaHCO3 )水溶液攪拌15分鐘,將混合溶液倒入萃取瓶中靜置分層,將下層水溶液倒入廢液桶中,再加入200毫升1N碳酸氫鈉水溶液倒入萃取瓶混合後靜置分層,將下層水溶液丟棄,收集有機層濃縮得18克粗產物(I)-e產物。28.8 g of the above product, 8.8 g of Methacrylic acid, 0.98 g of p-toluenesulfonic acid (PTSA) and 200 ml of toluene were placed in a 1 liter four-neck reaction flask; the reaction flask was equipped with a thermometer and distilled Water device. The reaction flask was stirred and heated to 112 ° C on a stirring heater. After collecting about 0.8 ml of water in a distillation water removal device, the reaction was observed by TLC. After the reaction was completed, the temperature was lowered to 90 ° C, and the temperature was kept slow. Add 200 ml of 1N aqueous solution of sodium hydrogencarbonate (NaHCO 3 ) and stir for 15 minutes. Pour the mixed solution into the extraction flask and let it stand. Pour the lower layer of the aqueous solution into the waste container, and then add 200 ml of 1N aqueous solution of sodium hydrogencarbonate. After the extracting flasks were mixed, the layers were allowed to stand, the lower aqueous solution was discarded, and the organic layer was collected to give 18 g of crude product (I)-e.

化合物(I)-e之純化 將約225克(樣品的15倍量)的管柱充填物(廠牌:Waters;規格:preparative C18 125)與225毫升的甲醇均勻攪拌混合後,緩緩倒入管柱(廠牌:Pyrex;規格:25G3)中進行充填,待管柱中的充填物緊密壓實後以等量的去離子水將甲醇置換掉,再繼續以1公升甲醇:水=9:1的沖堤液進行置換後,秤取粗產物(I)-e約17克緩緩倒入管柱中,先以約1公升甲醇:水=9:1的沖堤液以每瓶200毫升的量進行沖提收集後,改以每瓶100毫升繼續沖提收集並取樣以HPLC進行分析,約收集了2公升後開始有純度較高的目標產物出現,並以逆向TLC片(Merck RP-18 F254 S)進行沖堤終點判斷,待HPLC檢測結果完成後進行濃縮符合產品規格的樣品,即得到一呈現褐色油狀的目標產品。 Purification of Compound (I)-e Approximately 225 g (15 times the amount of sample) of the column packing (label: Waters; specification: preparative C18 125 After mixing with 225 ml of methanol, mix it slowly and slowly pour it into the column (label: Pyrex; size: 25G3) for filling. After the packed material in the column is compacted, the same amount of deionized water will be used. The methanol was replaced, and after replacing with 1 liter of methanol:water=9:1, the crude product (I)-e was weighed into about 17 grams and slowly poured into the column, first with about 1 liter of methanol. : Water = 9:1 rushing liquid is extracted and collected in an amount of 200 ml per bottle. After changing to 100 ml per bottle, it is continuously collected and sampled for analysis by HPLC. After about 2 liters, the purity is compared. High target product appeared, and the reverse TLC sheet (Merck RP-18 F 254 S) was used to judge the end point of the bank. After the HPLC test result was completed, the sample conforming to the product specification was concentrated to obtain a target product with a brown oil. .

化合物(I)-e 1 H NMR圖譜 1 H NMR(CDCl3 ):δ:11.81(s,1H),8.14(s,1H),7.92(q,2H),7.47(q,2H),7.20(s,1H),6.11(s,1H),5.56(s,1H),4.26(m,4H),3.63(m,12H),3.00(t,2H),2.74(t,2H),1.93(s,3H),1.50(s,9H)。 Compound (I)-e 1 H NMR spectrum 1 H NMR (CDCl 3 ): δ: 11.81 (s, 1H), 8.14 (s, 1H), 7.92 (q, 2H), 7.47 (q, 2H), 7.20 ( s, 1H), 6.11 (s, 1H), 5.56 (s, 1H), 4.26 (m, 4H), 3.63 (m, 12H), 3.00 (t, 2H), 2.74 (t, 2H), 1.93 (s , 3H), 1.50 (s, 9H).

實施例六Embodiment 6

溶解度試驗 實驗中使用市售Benzotriazole A【苯丙酸,3-(2H-苯並三唑-2-基)-5-(1,1-二甲基乙基)-4-羥基-,2-[(2-甲基-1-羰基-2-丙烯基)氧基]乙基酯;Benzenepropanoic acid,3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxy-,2-[(2-methyl-1-oxo-2-propenyl)oxy]ethyl ester】與化合物(I)-a、化合物(I)-b、化合物(I)-c、化合物(I)-d及化合物(I)-e,以40%異丙醇(IPA)/60%水之醇水系統進行溶解度測試。測試方法Commercially available Benzotriazole A [phenylpropionic acid, 3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxy-, 2- was used in the solubility test . [(2-Methyl-1-carbonyl-2-propenyl)oxy]ethyl ester; Benzenepropanoic acid, 3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4- Hydroxy-,2-[(2-methyl-1-oxo-2-propenyl)oxy]ethyl ester] with compound (I)-a, compound (I)-b, compound (I)-c, compound (I) -d and compound (I)-e, solubility test was carried out in an alcoholic water system of 40% isopropanol (IPA) / 60% water. testing method

在40%異丙醇(IPA)水溶液下之溶解度測定,其儀器組件如下所示:Waters 717autersampler,Waters 996 PDA(photodiode array detecter),Waters 600 pump,設定注射量為20 μ L,分析管柱:phenamex Luna C18,流速1mL/min,移動相為氰甲烷。在檢量線製作上,將樣品配製為1023 mg/L之40%IPA水溶液,並以序列稀釋方式稀釋為512.5 mg/L、102.5 mg/L經HPLC分析後,以面積對濃度作圖得檢量線,樣品在40%IPA水溶液下之溶解度測定上,首先將樣品在室溫下以40%IPA配製為飽和溶液,再將樣品稀釋,使其分析結果之吸收峰面積可在檢量範圍內,以檢量線回推其真實濃度。結果如圖1所示。The solubility of the solution in 40% isopropanol (IPA) aqueous solution was determined as follows: Waters 717autersampler, Waters 996 PDA (photodiode array detecter), Waters 600 pump, set injection volume 20 μL, analytical column: Phennamex Luna C18, flow rate 1 mL/min, mobile phase is cyanomethane. In the preparation of the calibration curve, the sample was prepared as a 1023 mg/L 40% IPA aqueous solution, and diluted to 512.5 mg/L and 102.5 mg/L by serial dilution. After HPLC analysis, the area was analyzed by concentration. Measuring line, the solubility of the sample in 40% IPA aqueous solution, firstly prepare the sample as a saturated solution at 40% IPA at room temperature, and then dilute the sample, so that the absorption peak area of the analysis result can be within the detection range. , push back the true concentration with the calibration line. The result is shown in Figure 1.

由圖1可知,以40%IPA/60%水之醇水系統進行溶解度試驗,其結果顯示本發明化合物(I)-a、化合物(I)-b、化合物(I)-c、化合物(I)-d及化合物(I)-e之溶解度測試,皆優於目前市售產品Benzotriazole A。As can be seen from Fig. 1, the solubility test was carried out in a 40% IPA/60% aqueous alcohol water system, and the results showed that the compound (I)-a, the compound (I)-b, the compound (I)-c, and the compound (I) of the present invention. The solubility test of -d and compound (I)-e is superior to the currently commercially available product Benzotriazole A.

實施例七Example 7

應用實驗 實驗中所用之原料及組成用量百分比如表二: HEMA:甲基丙烯酸2-羥基乙基酯(2-hydroxyethyl methacrylate)EGDMA:二甲基丙烯酸乙二醇酯(ethylene glycol dimethacrylate)I907:Irgacure 907購於Ciba公司TPO:Darocur TPO購於Ciba公司RUVA:化合物(I)-e Application Experiments The percentages of raw materials and composition used in the experiment are shown in Table 2: HEMA: 2-hydroxyethyl methacrylate EGDMA: ethylene glycol dimethacrylate I907: Irgacure 907 purchased from Ciba TPO: Darocur TPO purchased from Ciba RUVA: Compound (I)-e

以表二列舉該可聚合混合物之各組成份比例,合成水凝膠(hydrogel)的薄膜,薄膜厚度(thickness)約為0.18 mm到0.20 mm間。薄膜之穿透率圖譜(transmission spectrum)可用紫外線光譜儀(UV spectrophotomer)測定之,而各紫外線圖譜(UV sepctrum),詳如圖2所示。其中,實線()為配方1,虛線()為配方2。在應用實驗結果中,藉由紫外線穿透圖譜顯示,本發明新穎可聚合水溶性或醇溶性紫外光吸收劑單體應用於隱形眼鏡中有極佳之紫外光遮蔽效果。A hydrogel film was synthesized in the ratio of the respective components of the polymerizable mixture in Table 2. The film thickness was between 0.18 mm and 0.20 mm. The transmission spectrum of the film can be measured by a UV spectrophotomer, and each UV spectrum (UV sepctrum) is shown in detail in FIG. Among them, the solid line ( ) for recipe 1, dotted line ( ) is Formula 2. In the application experiment results, the novel polymerizable water-soluble or alcohol-soluble ultraviolet light absorber monomer of the present invention has an excellent ultraviolet light shielding effect in a contact lens by the ultraviolet light transmission pattern.

綜上所述,本發明確能藉所揭露之技術思想以達到發明目的,具新穎性、進步性與可供產業利用性,並與發明專利要件相符合。惟以上所揭示者,乃較佳實施例,舉凡局部之變更或修飾而源於本案之技術思想而為熟悉該項技術之人士所易於推知者,俱不脫本案之專利權範圍。In summary, the present invention can achieve the object of the invention by the disclosed technical idea, which is novel, progressive and available for industrial use, and is in conformity with the patent requirements of the invention. However, those disclosed above are preferred embodiments, and those that are modified or modified in part and derived from the technical idea of the present invention are easily inferred by those skilled in the art, and do not depart from the scope of the patent.

上述實施例僅係為了方便說明而舉例而已,本發明所主張之權利範圍自應以申請專利範圍所述為準,而非僅限於上述實施例。The above-mentioned embodiments are merely examples for convenience of description, and the scope of the claims is intended to be limited to the above embodiments.

圖1係本發明實施例六中,市售Benzotriazole A與本發明化合物(I)-a、化合物(I)-b、化合物(I)-c、化合物(I)-d及化合物(I)-e解度測試之結果。1 is a commercially available Benzotriazole A and a compound (I)-a, a compound (I)-b, a compound (I)-c, a compound (I)-d and a compound (I) in the sixth embodiment of the present invention. The result of the e-solution test.

圖2係本發明實施例七中,不含本發明化合物之配方1,以及含本發明化合物(I)-e之配方2,兩者之紫外線穿透圖譜。Figure 2 is a graph showing the ultraviolet penetrating spectrum of Formulation 1 containing no compound of the present invention and Formulation 2 containing Compound (I)-e of the present invention in Example 7 of the present invention.

Claims (11)

一種可聚合型水溶性或醇溶性之紫外光吸收劑單體,其係如式(I)所示: 其中,R1 為氫或C1 -C5 烷基,R2 為氫、氯、溴、或碘,R3 為氫或甲基,且m為3~12。A polymerizable water-soluble or alcohol-soluble ultraviolet light absorber monomer, which is represented by the formula (I): Wherein R 1 is hydrogen or C 1 -C 5 alkyl, R 2 is hydrogen, chlorine, bromine or iodine, R 3 is hydrogen or methyl, and m is from 3 to 12. 如申請專利範圍第1項所述之紫外光吸收劑單體,其中式(I)為 The ultraviolet light absorber monomer according to claim 1, wherein the formula (I) is 如申請專利範圍第1項所述之紫外光吸收劑單體,其中式(I)為 The ultraviolet light absorber monomer according to claim 1, wherein the formula (I) is 如申請專利範圍第1項所述之紫外光吸收劑單體,其中式(I)為 The ultraviolet light absorber monomer according to claim 1, wherein the formula (I) is 一種具紫外光吸收性能之聚合物,其包含:一可聚合單體,其如下式(I)所示: 其中,R1 為氫或C1 -C5 烷基,R2 為氫、氯、溴、或碘,R3 為氫或甲基,且m為3~12;以及至少一可聚合之共聚單體。A polymer having ultraviolet light absorbing properties, comprising: a polymerizable monomer, which is represented by the following formula (I): Wherein R 1 is hydrogen or C 1 -C 5 alkyl, R 2 is hydrogen, chlorine, bromine or iodine, R 3 is hydrogen or methyl, and m is 3 to 12; and at least one polymerizable copolymer body. 一種可聚合型水溶性紫外光吸收劑單體之製造方法,其包含:經由如下式(II)之化合物, 與式(III)之聚乙二醇(PEG;polyethylene glycol)進行反應, 獲得式(IV)化合物, 再將式(IV)化合物與式(V)之丙烯酸類化合物進行反應, 獲得如下式(I)所示之化合物, 其中,R1 為氫或C1 -C5 烷基,R2 為氫、氯、溴、或碘,R3 為氫或甲基,且x、m為3~12。A method for producing a polymerizable water-soluble ultraviolet light absorber monomer, comprising: a compound of the following formula (II), Reacting with polyethylene glycol (PEG) of formula (III), Obtaining a compound of formula (IV), Further reacting a compound of formula (IV) with an acrylic compound of formula (V), Obtaining a compound represented by the following formula (I), Wherein R 1 is hydrogen or C 1 -C 5 alkyl, R 2 is hydrogen, chlorine, bromine or iodine, R 3 is hydrogen or methyl, and x and m are 3 to 12. 一種可聚合型水溶性紫外光吸收劑單體之製造方法,其包含:經由如下式(II)之化合物, 與如下式(VI)之化合物進行反應, 而獲得如下式(I)所示之化合物, 其中,R1 為氫或C1 -C5 烷基,R2 為氫、氯、溴、或碘,R3 為氫或甲基,且n、m為3~12,但未使用聚合反應起始劑與鏈轉移劑。A method for producing a polymerizable water-soluble ultraviolet light absorber monomer, comprising: a compound of the following formula (II), Reacting with a compound of the following formula (VI), And obtaining a compound represented by the following formula (I), Wherein R 1 is hydrogen or C 1 -C 5 alkyl, R 2 is hydrogen, chlorine, bromine or iodine, R 3 is hydrogen or methyl, and n and m are 3 to 12, but no polymerization is used. Starter and chain transfer agent. 一種可防紫外線之隱形眼鏡,其係藉由如專利申請範圍第1項所述之單體,溶於親水性材料中製造而得。 An ultraviolet-shielding contact lens obtained by dissolving in a hydrophilic material as the monomer described in claim 1 of the patent application. 如專利申請範圍第8項所述之隱形眼鏡,其中該親水性材料包含水凝膠(hydrogel)或矽水凝膠(silicone hydrogel)。 The contact lens of claim 8, wherein the hydrophilic material comprises a hydrogel or a silicone hydrogel. 一種可防紫外線人工水晶體,其係藉由如專利申請範圍第1項所述之單體,溶於親水性材料中製造而得。 An ultraviolet-protectable artificial crystal, which is produced by dissolving in a hydrophilic material as the monomer described in the first application of the patent application. 如專利申請範圍第10項所述之人工水晶體,其中親水性材料包含水凝膠(hydrogel)或矽水凝膠(silicone hydrogel)。 The artificial crystal according to claim 10, wherein the hydrophilic material comprises a hydrogel or a silicone hydrogel.
TW97104292A 2008-02-04 2008-02-04 Polymerizable water-soluble or alcohol-soluble uv-light absorbent TWI381829B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW97104292A TWI381829B (en) 2008-02-04 2008-02-04 Polymerizable water-soluble or alcohol-soluble uv-light absorbent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW97104292A TWI381829B (en) 2008-02-04 2008-02-04 Polymerizable water-soluble or alcohol-soluble uv-light absorbent

Publications (2)

Publication Number Publication Date
TW200934458A TW200934458A (en) 2009-08-16
TWI381829B true TWI381829B (en) 2013-01-11

Family

ID=44866278

Family Applications (1)

Application Number Title Priority Date Filing Date
TW97104292A TWI381829B (en) 2008-02-04 2008-02-04 Polymerizable water-soluble or alcohol-soluble uv-light absorbent

Country Status (1)

Country Link
TW (1) TWI381829B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015168822A (en) * 2014-03-10 2015-09-28 中日合成化學股▲分▼有限公司 Liquid reactive ultraviolet absorber, method of producing the same and ultraviolet resistive polymer

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3116257C (en) * 2016-02-22 2024-01-16 Alcon Inc. Uv-absorbing vinylic monomers and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1149824A (en) * 1997-07-31 1999-02-23 Nidek Co Ltd Ultraviolet light absorbing substrate
JP2002226521A (en) * 2001-02-02 2002-08-14 Otsuka Chem Co Ltd Ultraviolet absorbing copolymer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1149824A (en) * 1997-07-31 1999-02-23 Nidek Co Ltd Ultraviolet light absorbing substrate
JP2002226521A (en) * 2001-02-02 2002-08-14 Otsuka Chem Co Ltd Ultraviolet absorbing copolymer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015168822A (en) * 2014-03-10 2015-09-28 中日合成化學股▲分▼有限公司 Liquid reactive ultraviolet absorber, method of producing the same and ultraviolet resistive polymer

Also Published As

Publication number Publication date
TW200934458A (en) 2009-08-16

Similar Documents

Publication Publication Date Title
JP2807217B2 (en) UV absorbing composition
JP5732455B2 (en) UV / Visible light absorbers for ophthalmic lens materials
US8329842B2 (en) Ophthalmological composition and use thereof
CN102712815B (en) Visible light absorbers for ophthalmic lens materials
KR101715689B1 (en) Visible light absorbers for ophthalmic lens materials
AU2015247438B2 (en) (meth)acrylamide polymers for contact lens and intraocular lens
CA2328912A1 (en) Polymerizable hydrophilic ultraviolet light absorbing monomers
JP7399962B2 (en) UV absorbing ophthalmic lenses
EP0892297A1 (en) Process for producing contact lens with hydrophilic surface and contact lens obtained thereby
EP3383969B1 (en) Optically upconverting liquid-filled polymeric materials
EP1931621B1 (en) Compounds suitable as polymerizable yellow dyes; polymerizable and/or crosslinkable compositions, polymer matrices and intraocular lenses containing same
TWI381829B (en) Polymerizable water-soluble or alcohol-soluble uv-light absorbent
US20150094439A1 (en) Stable polymerizable uv-absorbing colorant for intraocular lens
EP0899590B1 (en) Ultraviolet absorbing base material
US7915322B2 (en) Polymerizable water-soluble or alcohol-soluble ultraviolet absorber
CN115991710B (en) Blue light resistant cornea contact lens based on tetraarylporphyrin compound and preparation method thereof
US20160194424A1 (en) Monomers for use in a polymerizable composition and high refractive index polymer for opthalmic applications
CN110382628B (en) Polymerizable dye compound, preparation method, polymer containing dye and application
US6914086B2 (en) Crosslinkable UV absorbing agent for UV absorbing lens
JP6258664B2 (en) Polymerizable UV absorbing dye for intraocular lens
JPH09235309A (en) Lens material for eye containing ultraviolet ray-absorbing polymer not having polymerizable group and its production
JP3655061B2 (en) UV-absorbing substrate
JP4610366B2 (en) Plastic lens and manufacturing method thereof
JP2009235185A (en) Refining method of polymer, and polymer solution
KR102654801B1 (en) Blue light blocking hydrogel contact lens composition and hydrogel contact lens comprising the same

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees